登录

需要订阅 JoVE 才能查看此.

CD Marker Recognition of Human Cytokine-Induced Killer Cells by Flow Cytometry

-- views • 2:16 min

成績單

Cytokine-induced killer, CIK, cells are heterogeneous immune cell populations generated ex vivo from peripheral blood mononuclear cell (PBMC) cultures stimulated with specific cytokines and monoclonal antibodies. CIK cells comprise cell populations, including CD3+CD56+ NK-T cells, CD3+CD56- T cells, and CD3-CD56+ NK cells.

To determine the CIK cell proportion, begin with tubes containing a PBMC-derived CIK cell suspension. Add anti-CD3 and anti-CD56 antibodies conjugated to different fluorophores and their mixture to designated tubes. Add isotype control antibodies conjugated to similar fluorophores as specific antibodies into other tubes.

Fluorescently-labeled anti-CD3 and anti-CD56 antibodies recognize and bind to CD3 and CD56 expressed on CIK cell populations, respectively. Isotype control antibodies lack target antigen specificity, facilitating non-specific background signal measurements.

Pipette cells into round-bottom tubes with cell strainer caps, that help in removing cell aggregates. Load the tubes into a flow cytometer carousel. During the run, each cell passes through the channel and encounters the laser beams, scattering the light.

One detector measures the forward scattered light intensity, indicative of cell size; another measures the side scattered light intensity perpendicular to the laser beam, suggestive of cell granularity. Together, this information helps identify the immune cell population.

Simultaneously, laser beams of specific excitation wavelengths excite the fluorophore-conjugated antibodies on the cells, causing fluorescent signal emissions which are detected.

The analysis of specific fluorescent intensities on the cells determines the proportion of CIK cell subpopulations.

article

03:20

CD Marker Recognition of Human Cytokine-Induced Killer Cells by Flow Cytometry

相关视频

56 Views

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。